Subsequent ExomeDx® Reanalysis (charged)
Use
This test performs reanalysis of previously performed full exome sequencing (XomeDx®) data when new clinical information is available or phenotype has evolved. It focuses on newly implicated genes or reclassification of variants—including pathogenic, likely pathogenic, or medically actionable secondary findings per ACMG updates—to provide updated diagnostic insights based on current evidence.
Special Instructions
Ordering requires that a full exome analysis was previously completed at GeneDx. It is recommended to wait at least one year from prior analysis before ordering. The test code is 947. Secondary findings per ACMG are only returned if a full exome analysis is completed and patient consent includes secondary findings.
Limitations
This reanalysis is applicable only to prior XomeDx® (full exome) data performed at GeneDx and is not appropriate for other/broader sequencing data types. The test may not detect novel variants outside previously captured exome data or structural variants beyond original data capture. Gene/test content—including gene list and test definitions—are subject to change by GeneDx.
Methodology
NGS
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Not provided
Minimum Volume
Not provided